Jason Hsu serves as Executive at Immix Biopharma, Inc., where they oversee executive responsibilities. Since joining the company, Jason Hsu has executed 13 insider transactions totaling $813.6K, demonstrating a bullish approach to their equity position. Their most recent transaction on Aug 22, 2024 involved purchasing 8,100 shares valued at $18.2K.
Jason Hsu currently holds 845,300 shares of Immix Biopharma, Inc. (IMMX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jason Hsu has been a net buyer of IMMX stock. They have purchased $813.6K and sold $0 worth of shares.
Jason Hsu's most recent insider trade was on Aug 22, 2024, when they purchased 8,100 shares at $2.25 per share.
Get notified when new Form 4 filings are submitted
| $2.23 |
| Discretionary |
| Jul 24, 2024 | IMMX | $12.9K | Purchase | 6,000 | $2.15 | Discretionary |
| Jul 18, 2024 | IMMX | $6.6K | Purchase | 3,200 | $2.07 | Discretionary |
| Dec 11, 2023 | IMMX | $144.8K | Purchase | 31,000 | $4.67 | Discretionary |
| Dec 8, 2023 | IMMX | $122.0K | Purchase | 25,000 | $4.88 | Discretionary |
| Sep 15, 2023 | IMMX | $17.4K | Purchase | 7,000 | $2.49 | Discretionary |
| Sep 14, 2023 | IMMX | $25.8K | Purchase | 10,000 | $2.58 | Discretionary |
| Sep 12, 2023 | IMMX | $84.9K | Purchase | 30,000 | $2.83 | Discretionary |
| Sep 11, 2023 | IMMX | $72.3K | Purchase | 25,000 | $2.89 | Discretionary |
| Sep 8, 2023 | IMMX | $25.3K | Purchase | 10,000 | $2.53 | Discretionary |
| Dec 20, 2021 | IMMX | $250.0K | Purchase | 50,000 | $5.00 | Discretionary |
| Dec 20, 2021 | IMMX | $3.3M | Conversion | 3,915,913 | $0.85 | Discretionary |